Dushi Medicine Secures RMB 30 Million Series A Funding to Build China's Largest Family Doctor Platform

VCBeat (WeChat ID: vcbeat) has recently learned that Shenzhen Dushi Medical Limited By Share Co.,Ltd. (stock code: 870594), an internet-based pharmaceutical company, announced the completion of its RMB 30 million Series A financing round, led by Tianyi Investment Group (Zhongwei Fund). The proceeds from this round will be primarily allocated to the development of DTP pharmacies, technological research and development for the Dushi Medical Family Doctor Platform (the Expert Edition APP of Dushi Medical Network), and product promotion.

Shenzhen Dushi Medical Limited By Share Co.,Ltd. was established in May 2010 and listed on the National Equities Exchange and Quotations (NEEQ) on January 23, 2017. After years of development, Dushi Medical currently operates 50 self-owned chain pharmacies featuring DTP (Direct-to-Patient) services. Its online pharmacy business, primarily hosted on Tmall and JD.com platforms, ranks among the industry leaders.

To date, Dushi Medical’s business operations have encompassed chain pharmacies, online pharmacies, pharmaceutical wholesale, internet hospitals, and the Expert Edition of the Dushi Medical Network APP.

Since 2015, Shenzhen Dushi Medical Limited By Share Co.,Ltd. has been developing its Family Doctor Platform (the Dushi Medical Network Expert Edition APP). To date, tens of thousands of doctors from across China have joined the platform, attracting hundreds of thousands of patient followers. Through the platform, physicians can manage patients, provide disease education, increase their income, practice independently, and enhance their professional brand. Patients can access health consultations, follow-up visits, medication guidance, and dedicated family doctor services via the platform.

It is reported that Shenzhen Dushi Medical Limited By Share Co.,Ltd. will enter into a strategic cooperation with Meinian Onehealth, a subsidiary of Tianyi Investment Group, to integrate their omni-channel resources and build a more comprehensive service ecosystem encompassing medical care, health checkups, pharmaceutical supply, and health management.

Tianyi Capital, the investor, believes that Meinian Onehealth is China’s largest gateway to health services, while Shenzhen Dushi Medical Limited By Share Co.,Ltd. is an emerging force in the field of internet-based pharmaceutical diagnosis and treatment. The two parties share highly aligned service philosophies and can achieve complementary industrial advantages. Their collaboration will fully leverage ecosystem synergies, striving to maximize the value of shared ecosystems, ultimately benefiting more residents through more precise, personalized, and comprehensive medical and healthcare services.

Regarding future development, Chen Zheng, Chairman of Dushi Medical, stated that with the completion of this financing round, Dushi Medical will focus in 2018 on building its family doctor platform, recruiting more physicians to join the Dushi Medical Family Doctor Platform (the Expert Edition App of Dushi Medical Network), and upgrading its products and technology. Furthermore, through its internet hospital, the company will facilitate the implementation of multi-site practice for physicians, ultimately evolving into a medical service platform most trusted by both doctors and patients.